SPRY
SPRY
NASDAQ · Biotechnology

Ars Pharmaceuticals Inc

$7.57
-2.97 (-28.18%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +770.7% upside
Low Target $44.11
Average Target $65.91
High Target $67.85
Current Price $7.57
Current
$7.57
Target
$65.91
$44.11 $65.91 avg $67.85
Scenario Analysis
Bear Case
$44.11
482.7%
Low target
Base Case
$65.91
+770.7%
Avg target
Bull Case
$67.85
+796.3%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$18.90
-59.9% from high
52-Week Low
$6.66
+13.7% from low
Target vs 52W High
$65.91
+248.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +5.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -46.4%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +191.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.0%